Literature DB >> 6409012

Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.

T Morishima, F Tatsumi, E Fukada, M Saito, M Fujita, N Nagashima, S Hanawa.   

Abstract

Cysteinyldopas and Dopa in the urine and tissues of Japanese melanoma patients were investigated quantitatively by means of high-performance liquid chromatography. Cysteinyldopa isomers were detected in the urine of eumelanic Japanese patients. The amount (X +/- SD%) of each isomer of cysteinyldopa in the urine was 80.26 +/- 4.66% in 5-S-cysteinyldopa, 9.39 +/- 1.64% in 2-S-cysteinyldopa, 7.07 +/- 3.33% in 2, 5-S, S-dicysteinyldopa, and 3.28 +/- 1.43% in 6-S-cysteinyldopa. The amount of cysteinyldopa in melanoma tissues was 26-314 times more than that of Dopa. The amount (X +/- SD%) of cysteinyldopa in the tissues was 80.34 +/- 1.75% in 5-S-cysteinyldopa, 11.06 +/- 1.91% in 2-S-cysteinyldopa, 6.27 +/- 1.43% in 2, 5-S, S-dicysteinyldopa, and 2.34 +/- 0.61% in 6-S-cysteinyldopa. The fact that the percentages of each isomer of cysteinyldopa in the urine and in the tissues were approximately constant suggests that the cysteinyldopas secreted from melanoma cells were excreted into the urine without being metabolized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409012     DOI: 10.1007/BF00412878

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  14 in total

1.  Detection and quantitation of 5-S-cysteinyldopa in melanotic and amelanotic melanoma in comparison with nonpigment cell tumors and it's urinary excretion.

Authors:  M Mojamdar; M Ichihashi; Y Mishima
Journal:  J Dermatol       Date:  1979-12       Impact factor: 4.005

2.  Isolation of 2-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa from the urine of patients with melanoma.

Authors:  G Prota; H Rorsman; A M Rosengren; E Rosengren
Journal:  Experientia       Date:  1977-06-15

3.  Melanin pigmentation in mammals.

Authors:  G Prota; R H Thomson
Journal:  Endeavour       Date:  1976-01       Impact factor: 0.444

4.  Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.

Authors:  T Morishima; M Saito; S Hanawa
Journal:  J Dermatol       Date:  1981-08       Impact factor: 4.005

5.  Metabolism of 5-S-cyteinyldopa by O-methylation.

Authors:  G Agrup; B Falck; C Hansson; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

6.  5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.

Authors:  G Agrup; P Agrup; T Andersson; L Hafström; C Hansson; S Jacobsson; P E Jönsson; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

7.  Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection.

Authors:  C Hansson; G Agrup; H Rorsman; A M Rosengren; E Rosengren; L E Edholm
Journal:  J Chromatogr       Date:  1979-01-01

8.  Melanin-producing dendritic cells and histogenesis of malignant melanoma.

Authors:  E Paul; L Illig
Journal:  Arch Dermatol Res       Date:  1976-12-15       Impact factor: 3.017

9.  Urinary excretion of 5-S-cysteinyldopa in healthy Japanese.

Authors:  T Morishima; S Hanawa
Journal:  Acta Derm Venereol       Date:  1981       Impact factor: 4.437

10.  5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.

Authors:  G Agrup; T Andersson; B Falck; K Persson; H Rorsman; A M Rosengren; E Rosengren
Journal:  Acta Derm Venereol       Date:  1975       Impact factor: 4.437

View more
  4 in total

1.  Quantitative analysis of eumelanin and pheomelanin in human malignant-melanoma tissues.

Authors:  T Morishima; E Fukuda
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

2.  Preoperative diagnosis of malignant melanoma using the touch-fluorescence method.

Authors:  T Morishima; A Shibata; H Fujita; K Chino
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

3.  Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues.

Authors:  T Morishima; F Tatsumi; E Fukada; M Watanabe; N Nagashima; S Hanawa
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

4.  Tyrosinase-catalyzed conjugation of dopa with glutathione.

Authors:  S Ito; A Palumbo; G Prota
Journal:  Experientia       Date:  1985-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.